BioGeneration Ventures
VC · (Netherlands)
Sign up free to access full profile and submit your pitch.
About
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together. BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit. Historical successful investments include divestment of Dezima Pharma to Amgen for up to USD 1.55 billion in total deal value and in Acerta Pharma for up to USD 7 billion with a guaranteed payment of USD 4 billion. Both companies were co-founded by BGV in 2012 and 2013 respectively. The Acerta Pharma sale was the largest exit ever of a privately held European biotech company. BGV is based in Naarden, The Netherlands, and closely collaborates with Forbion.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of BioGeneration Ventures
Other investors that have backed the same portfolio companies as BioGeneration Ventures. Expand any entry to see the shared portfolio companies.
- 18 shared
Shared portfolio companies
- Azafaros B.V.
- Brandaris Therapeutics B.V.
- CATALYM GmbH
- Citryll BV
- Complement Therapeutics Ltd
- Confo Therapeutics
- Dualyx NV
- FundaMental Pharma GmbH
- Genase Therapeutics BV
- Mironid Limited
- NewAmsterdam Pharma Company N.V.
- NorthSea Therapeutics B.V.
- RhyGaze AG
- River BioMedics B.V.
- Tanai Therapeutics
- TargED Biopharmaceuticals B.V.
- Tessellate Bio B.V.
- VectorY
- 5 shared
Shared portfolio companies
- 5 shared
Shared portfolio companies
- CATALYM GmbH
- Citryll BV
- Epsilogen Ltd
- FundaMental Pharma GmbH
- RhyGaze AG
- 5 shared
Shared portfolio companies
- Artica Therapeutics BV
- Brandaris Therapeutics B.V.
- Cristal Delivery B.V.
- FundaMental Pharma GmbH
- Mellon Medical B.V.
- 4 shared
Shared portfolio companies
- 4 shared
Shared portfolio companies
- Avidicure Holding B.V.
- Confo Therapeutics
- Dualyx NV
- Tanai Therapeutics
- 3 shared
Shared portfolio companies
- 3 shared
Shared portfolio companies
- Artica Therapeutics BV
- VarmX B.V.
- XS Innovations B.V.
- 3 shared
Shared portfolio companies
- 2 shared
Shared portfolio companies
- Dualyx NV
- TargED Biopharmaceuticals B.V.
